Search Results
Results found for "Shane Wright"
- Adhesion GPCR Consortium Newsletter - May 2024
Thomas Südhof, but did not start working on them right away. AB: The next workshop will likely bring together some of the hottest adhesion GPCR research going on right Day of the Dead celebrations: This happens over the weekend during the end of October and takes the shape The meat on a rotating spit with its bright red/orange chili-based marinade (spicy but not hot) catches
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
Welcome GPCR Fans, Every discovery-phase decision you make shapes your entire pipeline trajectory—and Rethink translational success: How post-COVID insights and unconventional decision-making shaped Serafini is where the next wave of therapies—from allosteric modulators to computational targeting—will take shape GPCR Premium is designed for scientists who need the right intelligence, fast—without noise, distractions Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
Drug efficacy depends on which cells express the receptor Side effects are tied to where agonists bind Weight-loss This is the part labs often underplay: scientific culture shapes scientific possibility. localization were unexpectedly robust Reframing: Use the compound as a visualization tool Impact: Shared
- From GPCR Data Chaos to Decisive Action
Not possible when nothing’s built to surface the right insights early. I know how to ask the right scientific questions—and when to shift from analysis to execution. decisive action ✅ This is hands-on support —not passive advising p.s: Still unsure if this is the right
- Curve Shifts Don’t Lie, But Your Eyes Might
By the end, you’ll know how to choose the right test, design experiments with power built in, and validate ability to calculate how many replicates you really need for 95% confidence ✅ Tools to choose the right Specifically, you’ll be able to: Design experiments with the right replicate count to balance rigor and With the right methods, you’ll know (not hope) that your results are real, reproducible, and actionable
- New Tools, Smart Signals, and The Kenakin Brief
Maria Majellaro of Celtarys shares how her team translates medicinal chemistry into practical GPCR assay GIPR biased agonism enhances metabolic outcomes —with dual targeting showing synergistic glucose and weight
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
20th Annual GPCR-Based Drug Discovery Conference isn’t just another event—it’s where the frameworks shaping Those who act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won between stalled programs and breakthrough therapies often lies in a single insight delivered at the right
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Understanding why similar drugs perform differently in different patients These tools have now been shared Skills + respect + shared curiosity = long-term impact. How do we prevent lean muscle loss during weight loss? Why it matters: Muscle mass shapes longevity, resilience, and overall metabolic health.
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Specificity issues Some antibodies bind to shared epitopes across different proteins, which may lead following internalization and recycling upon activation. - High-throughput applications Bright Tag brightness and stability: the brighter and more stable the better the assay outcome. 2.
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
Each AMA feeds directly into next month’s lessons—your real-world challenges shape what comes next. Jens Carlsson shares how structure-based design, molecular dynamics, and smart collaboration turn models GPCR innovation is accelerating; act on the right signals today to shape tomorrow’s breakthroughs—and
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Terry's Corner – How Enzyme Inhibition Shapes Every Discovery Program Every molecule meets an enzyme Each session shapes next month’s lessons—so your challenges guide the content. From failing fast to embracing serendipity, Eric shares the mindset (and messy origin stories) that shaped Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Upcoming events: Major GPCR-focused symposiums and translational meetings are on the horizon — shaping Ajay Yekkirala shares the journey from academic pharmacologist to biotech entrepreneur—bridging curiosity Learn entrepreneurial lessons rarely shared with postdocs. Those who act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won
- From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry
But one academic spark—and the right mentor—changed his trajectory forever. From Empty Lab to GPCR Discovery Starting in an empty lab with just a shared desk, Alessandro and Antonella
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
My perspective on this challenge is shaped not by a 40-year journey at the bench, but by an expertise My work isn't just about the latest and best assay; it's about the framework that ensures the right assay data leads to the right decision.
- The Truth About GPCR Product Launches: Years in the Making
Eric Trinquet shares what it really takes to bring a product to life—from sketch to shelf. But a pattern emerged: some scaffolds showed dual responsiveness to pH through lifetime and brightness lanthanide probe design with Durham University (chemistry) → Discovery of pH-sensitive dual response (brightness
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
Thank you for sharing your perspective and helping us shape the future of the Dr. GPCR ecosystem! accidental discoveries could revolutionise women’s health Seven unanswered questions about blockbuster weight-loss
- Specific Functions of Melanocortin 3 Receptor (MC3R)
In addition to its function about weight gain and appetite control mechanisms of MC3R, recent studies aimed to point out the importance of the MC3R regulations in three main concepts: 1) its impact on weight
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Decoding PTH1R Gq Signaling Cryo-EM structures of Gq-bound PTH1R uncover glycan and loop-based mechanisms shaping inbox every Thursday, follow these simple steps: Select the Log In / Sign Up option located at the top right
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
GPCR programs stall not because the target was wrong, but because teams waited too long to test the right Early In Vivo Wins the Race When is the right time to move beyond cell assays? you get your molecule in vivo, the sooner you know whether anything’s happening—and whether it’s the right
- From Student to Mentor: What Alessandro Nicoli Learned About Leading in Science
Watch Episode 171 Mentoring in science is more than supervising—it’s about shaping the next generation In this podcast episode , Alessandro Nicoli shares how becoming the first PhD student in a new lab shaped “I remember my first day—we were even sharing the desk. Leadership as Shared Growth For Alessandro, mentorship is not about control but about growing together But at the same time, you pass the same struggle before… you shape the new generation too.”
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Exploit probe dependence to shape precision pharmacology. Want to avoid off-target effects? This is a chance to shape the next scientific consensus on how GPCRs work, signal, and fail. Why you need to be there: Learn how kinetic nuance shapes ligand design. Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Eric Trinquet shares in a special Dr. Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- Science Needs Rigor, But Also Joy
communicates under pressure • Space for curiosity, humor, and human connection For anyone searching for the "right
- A Setmelanotide-like Effect at MC4R Is Achieved by MC4R Dimer Separation
Due to increasing numbers of people with excess body weight, the MC4R has become a target of interest setmelanotide, a novel synthetic MC4R agonist, suggest a predominant role of the Gq/11 pathway regarding weight
- Identification and functional characterization of the sulfakinin and sulfakinin receptor in the...
knock down SK and SKR reduced the transcription levels of the target genes and increased their body weight In parallel, injection of SK caused a significant reduction in body weight and increase in mortality
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
The reserved indications, where Addex retains exclusive rights to develop its own independent GABAB PAM program, have also been expanded to include chronic cough, in addition to the rights to develop certain
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
It happened because the chemistry and the biology met in the right way. They exchanged instincts as much as data, and built a shared rhythm of problem-solving. Good collaborations share protocols. Great collaborations share momentum.
- How Schild Analysis Protects Your Conclusions in GPCR Research
Why this matters Receptor distribution shapes incretin hormone drug effects across islets and neural Acting on the right signals today shapes tomorrow’s breakthroughs — and prevents delays others won’t
- Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for ...
and, in this review, we have compared expression of GPCR mRNAs in human islets obtained from normal weight range donors, and those with a weight range classified as obese.
- How Collaboration Drives GPCR Discoveries
The future of discovery will belong to scientists who know how to build the right partnerships and stay That mindset shaped his partnership with JB, the chemist who would eventually help his lab visualize This is where GPCR science is heading: toward deeper integration, shared tools, and partnerships that

























